Allan J Tobin

Title: The Innovations of Allan J Tobin

Introduction

Allan J Tobin is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biomedical research, particularly in the area of autoimmune diseases. With a total of 11 patents to his name, Tobin's work has had a profound impact on the understanding and treatment of various medical conditions.

Latest Patents

Among his latest patents, Tobin has developed innovative solutions such as the "Cloned glutamic acid decarboxylase," which includes isolated polypeptides useful in ameliorating GAD-associated autoimmune diseases. This patent also outlines diagnostic and therapeutic methods for utilizing these peptides. Another notable invention is the "Nucleic acid encoding GAD65," which provides cDNA molecules that encode at least one epitope for autoantibodies to GAD. This invention includes cloning vehicles capable of replication and expression, as well as methods for detecting autoantibodies to GAD using the GAD polypeptides coded by the cDNA molecules.

Career Highlights

Tobin has had a distinguished career, working at the University of California, where he has contributed to various research projects and advancements in his field. His work has been instrumental in pushing the boundaries of knowledge in autoimmune disease research.

Collaborations

Throughout his career, Tobin has collaborated with notable colleagues, including Mark G Erlander and Daniel L Kaufman. These partnerships have fostered innovation and have led to significant advancements in their shared research interests.

Conclusion

Allan J Tobin's contributions to the field of biomedical research are noteworthy, with his patents paving the way for new diagnostic and therapeutic methods. His work continues to influence the understanding of autoimmune diseases and showcases the importance of innovation in medicine.